Zannini Laura, Delia Domenico, Buscemi Giacomo
Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy.
Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy
J Mol Cell Biol. 2014 Dec;6(6):442-57. doi: 10.1093/jmcb/mju045. Epub 2014 Nov 17.
The serine/threonine kinase CHK2 is a key component of the DNA damage response. In human cells, following genotoxic stress, CHK2 is activated and phosphorylates >20 proteins to induce the appropriate cellular response, which, depending on the extent of damage, the cell type, and other factors, could be cell cycle checkpoint activation, induction of apoptosis or senescence, DNA repair, or tolerance of the damage. Recently, CHK2 has also been found to have cellular functions independent of the presence of nuclear DNA lesions. In particular, CHK2 participates in several molecular processes involved in DNA structure modification and cell cycle progression. In this review, we discuss the activity of CHK2 in response to DNA damage and in the maintenance of the biological functions in unstressed cells. These activities are also considered in relation to a possible role of CHK2 in tumorigenesis and, as a consequence, as a target of cancer therapy.
丝氨酸/苏氨酸激酶CHK2是DNA损伤反应的关键组成部分。在人类细胞中,受到基因毒性应激后,CHK2被激活并磷酸化20多种蛋白质,以诱导适当的细胞反应,根据损伤程度、细胞类型和其他因素,这种反应可能是细胞周期检查点激活、凋亡或衰老诱导、DNA修复或损伤耐受。最近,还发现CHK2具有独立于核DNA损伤存在的细胞功能。特别是,CHK2参与了几个与DNA结构修饰和细胞周期进程有关的分子过程。在这篇综述中,我们讨论了CHK2在应对DNA损伤以及在未受应激细胞中维持生物学功能方面的活性。还结合CHK2在肿瘤发生中可能的作用以及因此作为癌症治疗靶点来考虑这些活性。